A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 therapies safe?

There is no question that incretin-based glucose-lowering medications have proven to be effective glucose-lowering agents. Glucagon-like peptide 1 (GLP-1) receptor agonists demonstrate an efficacy comparable to insulin treatment and appear to do so with significant effects to promote weight loss wit...

Full description

Saved in:
Bibliographic Details
Main Authors: Butler, Peter C., Elashoff, Michael, Elashoff, Robert, Gale, Edwin A.M.
Format: Artigo
Language:Inglês
Published: American Diabetes Association 2013
Subjects:
Point-Counterpoint
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3687282/
https://ncbi.nlm.nih.gov/pubmed/23645885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-2713
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items